Issue of Equity

Issue of Equity

Eco Animal Health Group Plc

24 September 2010

Eco Animal Health Group plc ("Eco" or the "Company")

The Company announces that on 24 September 2010, 309,404 new Ordinary shares of 5p each were issued to shareholders who elected to receive new shares instead of cash for the interim dividend declared by the directors on 10 August 2010 and who held Ordinary shares on the record date of 20 August 2010; and 18,000 new Ordinary shares to a former employee of the Company under an agreement made by the remuneration committee. The new shares, which will rank pari passu with the existing shares of the Company, are expected to be admitted to trading on 29 September 2010.

Following these issues, the Company has 52,105,172 shares in issue and the following directors' shareholdings have increased.

	Â	Â		Â	Â		Â	Â
			Number of			Shareholding			Percentage
			Shares held			post scrip			shareholding
			prior to scrip						post scrip
										Â
P Lawrence & family			11,013,297			11,106,171			21.31
Executive Chairman
										Â
K Stockdale			7,928			7,987			0.02
Finance Director
										Â
D Danson			14,598			14,598			0.02
Non Executive Director

Enquires:	Â	Â	Â	Â	Â	Â	Â
									Â
Eco Animal Health Group plc
Peter Lawrence, Executive Chairman								020 8336 6190
									Â

ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products. Our products for these global growth markets promote well-being in animals. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders.